Supplemental material
Open access
6,148
Views
27
CrossRef citations to date
0
Altmetric
Infection
A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients
Vanessa TaiebCreativ-Ceutical, London, UK; Correspondence[email protected]
http://orcid.org/0000-0003-0655-8630
, http://orcid.org/0000-0003-0655-8630
Hidetoshi IkeokaShionogi & Co. Ltd, Osaka, Japan;
, Fang-Fang MaCreativ-Ceutical, Paris, France;
, Katarzyna BorkowskaCreativ-Ceutical, Krakow, Poland;
, Samuel AballéaCreativ-Ceutical, Paris, France;
, Keiko ToneShionogi Limited, London, UK;
& Nobuo HirotsuHirotsu Clinic, Kanagawa, Japan
show all
Pages 1355-1364
|
Received 12 Oct 2018, Accepted 15 Feb 2019, Published online: 01 Apr 2019
Related Research Data
Child's flu-like illness on parental QoL
Source:
Wiley
Cap-dependent Endonuclease Inhibitor S-033188 for the Treatment of Influenza: Results from a Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study in Otherwise Healthy Adolescents and Adults with Seasonal Influenza
Source:
Oxford University Press (OUP)
Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
Source:
Public Library of Science (PLoS)
インフルエンザウイルス感染症に対するリン酸オセルタミビルの有効性および安全性の検討
Source:
The Japanese Association for Infectious Diseases
Assessment of Hemagglutinin Sequence Heterogeneity during Influenza Virus Transmission in Families
Source:
Oxford University Press (OUP)
A Randomized Controlled Trial
Source:
American Medical Association (AMA)
Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
Source:
Elsevier BV
Baloxavir Marboxil: A Review in Acute Uncomplicated Influenza.
Source:
Springer Science and Business Media LLC
Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections.
Source:
Oxford University Press (OUP)
A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China.
Source:
Chinese Journal of Mechanical Engineering
A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.
Source:
Elsevier BV
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Source:
Elsevier BV
A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials
Source:
SAGE Publications
Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate versus Oseltamivir for Treatment of Influenza: A Double-Blind, Randomized, Noninferiority Clinical Trial
Source:
Oxford University Press (OUP)
Comparison of Shedding Characteristics of Seasonal Influenza Virus (Sub)Types and Influenza A(H1N1)pdm09; Germany, 2007–2011
Source:
Public Library of Science (PLoS)
Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza A and B Virus Infections
Source:
Oxford University Press (OUP)
Systematic Review of Influenza A(H1N1)pdm09 Virus Shedding: Duration Is Affected by Severity, but Not Age
Source:
Wiley
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
Source:
Elsevier BV
Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children
Source:
Informa Healthcare
Heterogeneity in Viral Shedding Among Individuals With Medically Attended Influenza A Virus Infection
Source:
Oxford University Press. The Journal's web site is located at http://jid.oxfordjournals.org
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.